Insider Transactions in Q3 2021 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 23
2021
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,451
-6.83%
|
$41,667
$17.22 P/Share
|
|
Sep 21
2021
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
827
-4.43%
|
$13,232
$16.11 P/Share
|
|
Sep 21
2021
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
4,584
-4.42%
|
$73,344
$16.11 P/Share
|
|
Sep 21
2021
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
729
-2.0%
|
$11,664
$16.11 P/Share
|
|
Sep 21
2021
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
492
-4.43%
|
$7,872
$16.11 P/Share
|
|
Sep 20
2021
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
617
-3.2%
|
$9,255
$15.61 P/Share
|
|
Sep 20
2021
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
3,425
-3.2%
|
$51,375
$15.61 P/Share
|
|
Sep 20
2021
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
545
-1.48%
|
$8,175
$15.61 P/Share
|
|
Sep 20
2021
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
367
-3.2%
|
$5,505
$15.61 P/Share
|
|
Jul 13
2021
|
Atlas Venture Fund Xi, L.P. |
SELL
Other acquisition or disposition
|
Direct |
814,013
-10.0%
|
-
|